Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic – Higher HIV Burden for Women, Girls in Africa

Chart: HIV infections by age and sex in sub-Saharan Africa since 2010

The data show falling numbers of young men and women in sub-Saharan Africa with new HIV infections since 2010, but the percentage of infected women and girls also rising over that time. . . . → Read More: Infographic – Higher HIV Burden for Women, Girls in Africa

Trial Shows Antibody Neutralizes, Reduces HIV Virus

T-cell infected by HIV

Results from a clinical trial show an experimental one-time antibody therapy, even at low doses, lowers levels of HIV virus in people living with the disease. . . . → Read More: Trial Shows Antibody Neutralizes, Reduces HIV Virus

Roche, Global Fund to Build Local Diagnostic Processes

Transporting HIV tests

The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes

Clinical Trial Underway for One-Time Crispr HIV Treatment

Crispr-Cas9

A clinical trial is underway assessing a therapy for HIV infections that aims to eradicate the virus with one dose of the gene-editing technique Crispr. . . . → Read More: Clinical Trial Underway for One-Time Crispr HIV Treatment

FDA Okays One-Time HIV Treatment Clinical Trial

HIV released from cell

A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial

Gates Grant Funds HIV-Birth Control Implant

T-cell infected by HIV

A biotechnology company received a foundation grant for an implanted device to prevent HIV infection and unwanted pregnancy in women. . . . → Read More: Gates Grant Funds HIV-Birth Control Implant

Cancer Immunotherapy Adapted for HIV

T-cell infected by HIV

A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections. . . . → Read More: Cancer Immunotherapy Adapted for HIV

Monthly HIV Drug Combo Approved by FDA

HIV released from cell

The Food and Drug Administration approved a drug regimen given once a month to control HIV infections, to replace daily antiretroviral medications. . . . → Read More: Monthly HIV Drug Combo Approved by FDA

Crispr Edits Out HIV-Like Genes from Monkey DNA

Kamel Khalili and Tricia Burdo

Researchers show the gene-editing technique Crispr can remove genes gained from infections similar to HIV in lab monkeys, as well as viral signals from their bodies. . . . → Read More: Crispr Edits Out HIV-Like Genes from Monkey DNA

Engineered Immune, Stem Cells Studied for HIV Cure

HIV released from cell

Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections. . . . → Read More: Engineered Immune, Stem Cells Studied for HIV Cure